Activation of nitric oxide signaling through muscarinic receptors in submandibular glands by primary Sjogren Syndrome antibodies

Clinical Immunology

Volumn 90, Issue 2, 1999, Pages 190-195

  Leirós, Claudia Ṕerez ^a   Sterin Borda, Leonor ^a   Hubscher, Osvaldo ^a   Arana, Roberto ^a   Borda, Enri S ^a  

^a Centre de Estudios Farmacologicos y Botanicos   (Argentina)

Author keywords

Muscarinic receptors; Sjogren's syndrome; Submandibular glands

Indexed keywords

ATROPINE; AUTOANTIBODY; CARBACHOL; CYCLIC GMP; IMMUNOGLOBULIN G; MUSCARINIC RECEPTOR; NITRIC OXIDE; PIRENZEPINE;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; HUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SJOEGREN SYNDROME; SUBMANDIBULAR GLAND;

EID: 0032926895     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1998.4640     Document Type: Article

References (35)

1. Jacobsson, L. T. H., and Manthorpe, R., Epidemiology of Sjögren's syndrome. Rheumatol. Europe 24, 46-47, 1995.
2. Strand, V., and Talal, N., Advances in the diagnosis and concept of Sjögren's syndrome (autoimmune exocrinopathy). Bull. Rheum. Dis. 92, 212-226, 1980.
3. Manthorpe, R., Andersen, V., Jensen, O. A., Oxholm, P., Prause, J. U., and Schødt, M., Editorial comments to the four sets of criteria for Sjögren's syndrome. Scand. J. Rheumatol. 61, 31-35, 1986.
4. Alexander, E. L., Hirsh, T. J., Arnett, F. C., Provost, T. T., and Stevens, M. B., Ro (SS-A) and La (SS-B) antibodies in the clinical spectrum of Sjögren's syndrome. J. Rheumatol. 9, 239-246, 1992.
5. Youinou, P., Adler, Y., Muller, S., Lamour, A., Baron, D., and Humbel, R. L., Anti-Ro (SSA) and anti-La (SSB) antibodies in autoimmune rheumatic disease. Clin. Rev. Allergy. 12, 253-274, 1994.
6. Asmussen, K., Andersen, V., Bendixen, G., Bendtzen, K., Prause, J. U., Thorn, J., Wiik, A., and Oxholm, P., Quantitative assessment of clinical disease status in primary Sjögren's Syndrome. Scand. J. Rheumatol. 26, 197-205, 1997.
7. Manthorpe, R., Asmussen, K., and Oxholm, P., Primary Sjögren's syndrome diagnostic criteria, clinical features and disease activity. J. Rheumatol. 24 (Suppl. 50), 8-11, 1997.
8. Fox, R. I., and Maruyama, T., Pathogenesis and treatment of Sjögren's syndrome. Curr. Opin. Rheumatol. 9, 393-399, 1997.
9. 3 muscarinic receptors in primary Sjögren's syndrome. Clin. Exp. Immunol. 104, 454-459, 1996.
10. 3 muscarinic acetylcholine receptors in patients with primary Sjögren's syndrome. Inv. Ophtalmol. Vis. Sci. 39, 151-156, 1998.
11. Buyon, J. P., Waltuck, J., Kleinman, C., and Copel, J., In utero identification and therapy of congenital heart block (CHB). Lupus 4, 116-121, 1995.
12. Waltuck, J., and Buyon, J. P., Autoantibody associated complete heart block: Outcome in mothers and children. Ann. Intern. Med. 120, 544-551, 1994.
13. Bacman, S., Sterin Borda, L., Camusso, J. J., Hubscher, O., Arana, R., and Borda E., Circulating antibodies against neurotransmitter recetor activities in children with congenital heart block and their mothers. FASEB J. 8, 1170-1176, 1994.
14. Borda, E., Camusso, J. J., Perez Leiros, C., Bacman, S., Hubscher, O., Arana, R., and Sterin Borda, L., Circulating antibodies against neonatal cardiac muscarinic acetylcholine receptor in patients with Sjögren's syndrome. Mol. Cell. Biochem. 163/164, 335-341, 1996.
15. Quissell, D. O., Watson, E., and Dowd, F. J., Signal transduction mechanisms involved in salivary gland regulated exocytosis. Cr. Rev. Oral Biol. Med. 3, 83-107, 1992.
16. Laniyou, A., Sliwinski-Lis, E., and Fleming, N., Muscarinic M3 receptors are coupled to two signal transduction pathways in rat submandibular cells. Eur. J. Pharmacol. 188, 171-174, 1990.
17. Borda, E., Perez Leiros, C., Camusso, J. J., Bacman, S., and Sterin Borda, L., Differential cholinoceptor subtype-dependent activation of signal transduction pathways in neonatal versus adult rat atria. Biochem. Pharmacol. 53, 959-967, 1997.
18. Damas, J., Pilocarpine-induced salivary secretion, kinin system and nitric oxide in rats. Arch. Int. Physiol. Biochim. Biophys. 102, 103-105, 1994.
19. Bodis, S., and Haregewoin, A., Evidence for the release and possible neural regulation of nitric oxide in human saliva. Biochem. Biophys. Res. Comm. 194, 347-350, 1993.
20. Dartt, D. A., Signal transduction and control of lacrimal gland protein secretion: a review. Curr. Eye. Res. 8, 619-636, 1989.
21. Konttinen, Y. T., Platts, L. A. M., Tuominen, S., Eklund, K. K., Santavirta, N., Törnwall, J., Sorsa, T., Hukkanen, M., and Polak, J. M., Role of nitric oxide in Sjögren's Syndrome. Arthritis Rheum. 40, 875-883, 1997.
22. Vitali, C., Bombardieri, S., Moutsopoulos, H. M., Balestrieri, G., Bencirelli, W., et al., Preliminary criteria for the classification of Sjögren's Syndrome: Results of a prospective concerted action supported by the European Community. Arthritis. Rheum. 36, 340-347, 1993.
23. Goin, J. C., Perez Leiros, C., Borda, E., and Sterin Borda, L., Interaction of human chagasic IgG with the second extracellular loop of the human heart muscarinic acetylcholine receptor: functional and pathological implications. FASEB J. 10, 77-83, 1997.
24. Bredt, D. S., and Snyder, S. H., Nitric oxide mediates glutamate-linked enhancement of cyclic GMP levels in the cerebellum. Proc. Natl. Acad. Sci. USA 86, 9030-9033, 1989.
25. Edwards, A. V., and Garret, J. R., Nitric oxide-related vasodilator responses to parasympathetic stimulation of the submandibular gland in the cat. J. Physiol. 464, 379-392, 1993.
26. Sterin Borda, L., Vila, E. A., Perez Leiros, C., Genaro, A., and Borda, E., Endogenous nitric oxide signalling system and the cardiac muscarinic acetylcholine receptor-inotropic response. Br. J. Pharmacol. 115, 1525-1531, 1995.
27. Fleming, J. W., Wisler, P. L., and Watanabe, A. M., Signal transduction by G proteins in cardiac tissues. Circulation 85, 420-433, 1992.
28. Luetje, C. W., Gierschik, P., Milligan, G., Unson, C., Speigel, A., and Nathanson, N., Tissue-specific regulation of GTP-binding protein and muscarinic acetylcholine receptor levels during cardiac development. Biochemistry 26, 4876-4884, 1987.
29. 2 muscarinic receptor binding sites in the murine cerebral cortex and heart. J. Pharmacol. Exp. Ther. 235, 612-618, 1985.
30. Buyon, J. P., Autoantibodies with Ro (SSA) and La (SSB) and pregnancy. J. Rheumatol. 24 (suppl 50), 12-16, 1997.
31. Buyon, J. P., Tseng, C. E., Di Donate, F., Rashbaum, W., Morris, A., and Chan, E. K. L., Cardiac expression of 52 β, an alternative transcript of the congenital heart block-associated 52-kd SS-A/Ro autoantigen, is maximal during fetal development. Arthritis. Rheum. 40, 655-660, 1997.
32. 2 in patients with idiopathic dilated cardiomyopathy. J. Clin. Invest. 91, 1964-1968, 1993.
33. Hopp, P. A., and Woods, K. R., Prediction of protein antigenic determinants from amino acid sequences. Proc. Natl. Acad. Sci. USA 78, 3824-3828, 1981.
34. 1-L-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J. Clin. Invest. 86, 1658-1663, 1990.
35. 2 muscarinic acetylcholine receptors by autoantibodies from patients with Chagas' disease. J. Biol. Chem. 272, 12989-12993, 1997.